Precise profiling of exosomal biomarkers via programmable curved plasmonic nanoarchitecture-based biosensor for clinical diagnosis of Alzheimer's disease
Biosensors and Bioelectronics · 2023-06 · 230 · 115269
DOI: 10.1016/j.bios.2023.115269 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2023-06. Verfasst von Sojin Song und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biological Engineering, Korea University, Seoul, 02841, Republic of Korea. Hauptthemen laut MEDLINE: Alzheimer Disease, Neurodegenerative Diseases, Biosensing Techniques, MicroRNAs. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: National Research Foundation of Korea, Korea Dementia Research Center, Korea Ministry of Science and ICT.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD) is a neurodegenerative disease of complex pathogenesis, with overt symptoms following disease progression. Early AD diagnosis is challenging due to the lack of robust biomarkers and limited patient access to diagnostics via neuroimaging and cerebrospinal fluid (CSF) tests. Exosomes present in body fluids are attracting attention as diagnostic biomarkers that directly reflect neuropathological features within the brain. In particular, exosomal miRNAs (exomiRs) signatures are involved in AD pathogenesis, showing a different expression between patients and the healthy controls (HCs). However, low yield and high homologous nature impede the accuracy and reproducibility of exosome blood-based AD diagnostics. Here, we developed a programmable curved plasmonic nanoarchitecture-based biosensor to analyze exomiRs in clinical serum samples for accurate AD diagnosis. To allow the detection of exomiRs in serum at attomolar levels, nanospaces (e.g., nanocrevice and nanocavity) were introduced into the nanostructures to dramatically increase the spectral sensitivity by adjusting the bending angle of the plasmonic nanostructure through sodium chloride concentration control. The developed biosensor classifies individuals into AD, mild cognitive impairment (MCI) patients, and HCs through profiling and quantifying exomiRs. Furthermore, integrating analysis expression patterns of multiple exosomal biomarkers improved serum-based diagnostic performance (average accuracy of 98.22%). Therefore, precise, highly sensitive serum-derived exosomal biomarker detection-based plasmonic biosensor has a robust capacity to predict the molecular pathologic of neurodegenerative disease, progression of cognitive decline, MCI/AD conversion, as well as early diagnosis and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical and Biological Engineering, Korea University, Seoul, 02841, Republic of Korea.
- Department of Chemical and Biological Engineering, Korea University, Seoul, 02841, Republic of Korea; Department of Chemical Engineering, Sunchon National University, Jeollanam-do, 57922, Republic of Korea.
- Korea University Anam Hospital, Seoul, 02841, Republic of Korea.
- Department of Chemical and Biological Engineering, Korea University, Seoul, 02841, Republic of Korea. Electronic address: simsj@korea.ac.kr.
Förderung
- National Research Foundation of Korea
- Korea Dementia Research Center
- Korea Ministry of Science and ICT
- Ministry of Education
- Korea University Anam Hospital
- Ministry of Science, ICT and Future Planning
- Ministry of Health and Welfare
- Korea Health Industry Development Institute
Zitieren
APA
Song, S., Lee, J. U., Jeon, M. J., Kim, S., Lee, C. N., & Sim, S. J. (2023). Precise profiling of exosomal biomarkers via programmable curved plasmonic nanoarchitecture-based biosensor for clinical diagnosis of Alzheimer's disease. Biosensors and Bioelectronics, 230, 115269. https://doi.org/10.1016/j.bios.2023.115269
Vancouver
Song S, Lee JU, Jeon MJ, Kim S, Lee CN, Sim SJ. Precise profiling of exosomal biomarkers via programmable curved plasmonic nanoarchitecture-based biosensor for clinical diagnosis of Alzheimer's disease. Biosensors and Bioelectronics. 2023;230:115269. doi:10.1016/j.bios.2023.115269
BibTeX
@article{Song2023,
author = {Song, Sojin and Lee, Jong Uk and Jeon, Myeong Jin and Kim, Soohyun and Lee, Chan-Nyoung and Sim, Sang Jun},
title = {Precise profiling of exosomal biomarkers via programmable curved plasmonic nanoarchitecture-based biosensor for clinical diagnosis of Alzheimer's disease},
journal = {Biosensors and Bioelectronics},
year = {2023},
volume = {230},
pages = {115269},
doi = {10.1016/j.bios.2023.115269}
}
EUVIMED